Mortality and recurrence patterns of breast cancer patients diagnosed under a screening programme versus comparable non-screened breast cancer patients from the same population: Analytical survey from 2002 to 2012

Tumor Biology

Volumn 35, Issue 3, 2014, Pages 1945-1953

  Garcia Fernandez A ^a,b   Chabrera, C ^c,d   Garcia Font M ^e   Fraile, M ^a   Lain, J M ^f   Gonzalez S ^a   Corral, C ^f   Torras, M ^a   Torres, J ^a   Teixido, M ^f   Barco, I ^a   Lopez R ^g   Gonzalez C ^a   Pessarrodona, A ^a   Gimenez N ^a,h  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT CATALÀ DE LA SALUT   (Spain)

^c School of Health Sciences   (Spain)

^d CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^e UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

^f HOSPITAL DE TERRASSA   (Spain)

^g GENERALITAT DE CATALUNYA   (Spain)

^h UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Breast neoplasms; Mass screening; Mortality

Indexed keywords

ADULT; AGED; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SCREENING; CONSERVATIVE TREATMENT; DISEASE FREE INTERVAL; DISTANT METASTASIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MASS SCREENING; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SENTINEL LYMPH NODE BIOPSY;

AGED; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MAMMOGRAPHY; MIDDLE AGED; RECURRENCE; TIME FACTORS;

EID: 84898845856     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1260-7     Document Type: Review

References (31)

1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374-403.
2. National Cancer Institute (2013) SEER stat fact sheets: breast. http://seer.cancer.gov/statfacts/html/breast.html. Accessed 17 Apr 2013.
3. Baum M, Ravdin PM. Decision-making in early breast cancer: guidelines and decision tools. Eur J Cancer. 2002;38:745-9.
4. Silverstein MJ, Skinner KA, Lomis TJ. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg. 2001;25:767-72.
5. Da B, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:1784-92.
6. Kopans DB. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer. 2002;94:580-1.
7. Altekruse S, Kosary C, Krapcho M, et al. SEER cancer statistics review, 1975-2007. Bethesda, MD: National Cancer Institute; 2010.
8. Duffy SW, Tabár L, Chen HH, et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish countries. Cancer. 2002;95:458-69.
9. Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography. I. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev. 2006;15:45-51.
10. Tabár L, Vitak B, Chen HH, Yen MF, Duffy SW, Smith RA. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer. 2001;91:1724-31.
11. Hellquist BN, Duffy SW, Abdsaleh S, et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer. 2011;117:714-22.
12. Otto SJ, Fracheboud J, Looman CW, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet. 2003;361:1411-7.
13. Paci E, EUROSCREEN Working Group. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen. 2012;19 Suppl 1:5-13.
14. Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA. 2009;302:1685-92.
15. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2011;1, CD001877.
16. Lietzen LW, Sorensen GV, Ordin AG, et al. Survival of women with breast cancer in central and northern Denmark, 1998-2009. Clin Epidemiol. 2011;3 Suppl 1:35-40.
17. Zahl PH, Maehlen J, Welch HG. The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med. 2008;168:2311-6.
18. Kopans DB, Smith RA, Duffy SW. Mammographic screening and "overdiagnosis". Radiology. 2011;260:616-20.
19. Jorgensen KJ, Keen JD, Gotzsche PC. Is mammographic screening justifiable considering its substantial overdiagnosis rate and minor effect on mortality? Radiology. 2011;260:621-7.
20. Peckham CS, Dezateux C. Issues underlying the evaluation of screening programmes. Br Med Bull. 1998;54:767-78.
21. Penston J. Should we use total mortality rather than cancer specific mortality to judge cancer screening programmes? Yes. BMJ. 2011;343:d6395.
22. Steele R, Brewster D. Should we use total mortality rather than cancer specific mortality to judge cancer screening programmes? No. BMJ. 2011;343:d6397.
23. Espinas JA, Aliste L, Fernandez E, Argimon JM, Tresserras R, Borras JM. Narrowing the equity gap: the impact of organized versus opportunistic cancer screening in Catalonia (Spain). J Med Screen. 2011;18:87-90.
24. Jorgensen KJ, Gotzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ. 2009;339:b2587.
25. Ackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ. 2006;332:689-92.
26. García Fernández A, Chabrera C, García Font M, et al. Positive versus negative sentinel nodes in early breast cancer patients: axillary or loco-regional relapse and survival. A study spanning 2000-2012. Breast. 2013;22:902-7.
27. Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med. 2011;155:481-92.
28. Ministerio de Sanidad y Consumo. Instituto de Salud "Carlos III". Agencia de Evaluación de Tecnologías Sanitarias (AETS). Cribado Poblacional de Cáncer de Mama mediante Mamografía. Madrid: AETS. Instituto de Salud "Carlos III", 1995.
29. Warner E. Breast-cancer screening. N Engl J Med. 2011;365:1025-32.
30. Autier P, Boniol M, Gavin A, Vatten LJ. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ. 2011;343:d4411.
31. Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med. 2007;146:502-10.